ABT Abbott Laboratories Common Stock
$114,41
Precio · Ago 21, 2026
Fundamentales a fecha de Jul 28, 2026
Rango 52S
$82–$137
58% of range
Calificación del Analista
BUY
33 analysts
Precio Objetivo
$119
+4% upside
P/E (TTM)
30.8
ROE
13.1%
Margen de Beneficio Neto
14.7%
Acerca de Abbott Laboratories Common Stock Descripción general de la empresa de Wikipedia
Abbott Laboratories es una compañía farmacéutica estadounidense, fundada en Chicago en 1888 por Wallace Calvin Abbott, con sede en Abbott Park, al norte de Chicago (Illinois). Hoy Abbott cuenta con aproximadamente 100 mil empleados.
Leer más
Abbott Laboratories es una compañía farmacéutica estadounidense, fundada en Chicago en 1888 por Wallace Calvin Abbott, con sede en Abbott Park, al norte de Chicago (Illinois). Hoy Abbott cuenta con aproximadamente 100 mil empleados.
Historia
En 1888, el médico Wallace C. Abbott comienza la fabricación de dosímetros de gránulos y pastillas pequeñas que permiten una determinación más exactos y más efectivos tratamientos, utilizando los elementos activos de plantas medicinales. En 1900, el grupo de Abbott se crea bajo el nombre de "Abbott Alkaloidal Company". Ya para 1906, Abbott establece su primera red médica, y en 1910, el laboratorio se mudó a New York, San Francisco, Seattle, Toronto, en India y Europa (Londres). En 1915, el laboratorio pasó a llamarse "Abbott".
En 1916, adquiere su primera droga sintética, Chlorazene, un agente antiséptico utilizado en los campos de batalla de la guerra para limpiar las heridas. Recién en 1923, entra en el campo de la anestesia con el desarrollo de un nuevo medicamento, el Butyn, n-butil-a base de alcohol. En 1930, lanzó uno de sus productos más conocidos, el fármaco sedante e hipnótico Nembutal. Este producto tenía una particularidad que le hacía resistente entre sus usuarios finales: su particularmente larga vida útil.
En 1936, lanzó el pentotal que será la más común inducción anestésica en el mundo por más de 50 años y permitirá el desarrollo de la cirugía moderna.
Expansión
En 1941, Gran Bretaña busca ayuda para la producción a gran escala de la penicilina (descubierta en 1928), otros antibióticos y toda clase de fármacos medicinales para los soldados ingleses y aliados. Las directivas de Abbott están de acuerdo, y en 1946, Abbott es el primer grupo farmacéutico al que se le oferta para construir un laboratorio especial para radiofármacos.
En el inicio de los 80, y con la aparición del virus de inmunodeficiencia humana (VIH), los laboratorios Abbott dan comienzo a sus actividades en inmunodiagnóstico. Ya en 1985, lanzan al mercado el primer kit para pruebas de detección del VIH en humanos.
Áreas de trabajo
Abbott está presente en las siguientas áreas de la ciencia y medicina, tanto humana como animal:
Línea farmacéutica: con antibióticos, desde el comienzo de la década de 1950. En particular las patologías de origen inmune, proporcionando tratamientos [VIH] desde la década de 1980 y desde 1989 con un Centro de Investigación en Worcester, Massachusetts.
Diabetes: con dispositivos de monitoreo de glucosa y medicamentos, desde la adquisición de MediSense en 1996.
Biología molecular: realizando análisis de ADN, ARN, y proteínas a nivel molecular, Abbot opera en las áreas de enfermedades genéticas desde 2001, con la adquisición de Vysis y la creación de "Abbott Molecular" en diciembre de 2003.
Nutrición: destinada a bebés, niños, adultos con diabetes, adultos sanos y pacientes.
Vascular: con dispositivos de cierre vascular, tecnologías endovasculares y coronarias, y lo referente a enfermedades cardiovasculares.
Salud animal: anestesia para animales, dietas líquidas Clinicare animales y otros productos veterinarios.
Línea diagnóstico/electromedicina: con instrumentos y productos destinados a la hematología, inmunodiagnóstico, oncología clínica y química (incluyendo el i-Stat, capaz de proporcionar análisis urgente del paciente en pocos minutos).
== Referencias ==
Fuente: Wikipedia, CC BY-SA 4.0 · Ver en Wikipedia ↗
ABT Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$114.41
Capitalización Bursátil
$228.62B
P/E (TTM)
30.8
BPA (TTM)
$3.72
Ingresos (TTM)
$44.33B
Rendimiento div.
1.8%
ROE
13.1%
Deuda/Capital
0.2
Rango 52S
$82 – $137
ABT Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$44.33B
2016-12-31
→
2025-12-31
BPA
$3.72
2016-12-31
→
2025-12-31
Flujo de caja libre
$7.39B
2016-12-31
→
2025-12-31
Márgenes
14.7%
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
ABT
Mediana de Pares
P/E (TTM)
30.8
27.5
P/S (TTM) (P/V (TTM))
5.2
6.0
P/B (P/C)
4.4
3.7
EV / EBITDA
28.9
—
Price / FCF (Precio / FCF)
30.9
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
ABT
Mediana de Pares
Operating Margin (Margen Operativo)
18.2%
—
Net Profit Margin (Margen de Beneficio Neto)
14.7%
-34.1%
ROA
7.8%
-24.9%
ROE
13.1%
-49.7%
ROIC
9.5%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
ABT
Mediana de Pares
Debt / Equity (Deuda / Patrimonio)
0.2
—
Current Ratio (Ratio corriente)
1.6
5.5
Quick Ratio (Ratio Rápido)
1.0
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
ABT
Mediana de Pares
Revenue YoY (Ingresos interanuales)
5.7%
—
Revenue CAGR 3Y (Ingresos CAGR 3A)
0.51%
—
Revenue CAGR 5Y (Ingresos CAGR 5A)
5.1%
—
EPS YoY (EPS interanual)
-51.3%
—
Net Income YoY (Beneficio Neto interanual)
-51.3%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
ABT
Mediana de Pares
Payout Ratio (Ratio de Pago)
63.1%
—
Dividendos Rendimiento, ratio de pago, historial de dividendos, CAGR a 5 años
Rendimiento por Dividendo
1.8%
Ratio de Pago
63.1%
CAGR de Dividendos a 5 años
—
| Fecha ex-dividendo | Monto |
|---|---|
| 15 de julio de 2026 | $0,6300 |
| 15 de abril de 2026 | $0,6300 |
| 15 de enero de 2026 | $0,6300 |
| 15 de octubre de 2025 | $0,5900 |
| 15 de julio de 2025 | $0,5900 |
| 15 de abril de 2025 | $0,5900 |
| 15 de enero de 2025 | $0,5900 |
| 15 de octubre de 2024 | $0,5500 |
| 15 de julio de 2024 | $0,5500 |
| 12 de abril de 2024 | $0,5500 |
| 11 de enero de 2024 | $0,5500 |
| 12 de octubre de 2023 | $0,5100 |
| 13 de julio de 2023 | $0,5100 |
| 13 de abril de 2023 | $0,5100 |
| 12 de enero de 2023 | $0,5100 |
| 13 de octubre de 2022 | $0,4700 |
| 14 de julio de 2022 | $0,4700 |
| 13 de abril de 2022 | $0,4700 |
| 13 de enero de 2022 | $0,4700 |
| 14 de octubre de 2021 | $0,4500 |
ABT Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
33 analistas
- Compra fuerte 11 33,3%
- Compra 13 39,4%
- Mantener 9 27,3%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
25 analistas · 2026-08-20
Mediana
$120.00
Ahora
$114.41
Mín
$103.00
Máx
$135.00
Objetivo mediano
$120.00
+4,9%
Objetivo medio
$119.40
+4,4%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-0.00%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $1.31 | $1.29 | 0.02% |
| 31 de marzo de 2026 | $1.15 | $1.16 | -0.01% |
| 31 de diciembre de 2025 | $1.50 | $1.51 | -0.01% |
| 30 de septiembre de 2025 | $1.30 | $1.31 | -0.01% |
| 30 de junio de 2025 | $1.26 | $1.27 | -0.01% |
| 31 de marzo de 2025 | $1.09 | $1.08 | 0.01% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
| ISRG | $201.11B | 72.0 | 20.5% | 28.4% | 16.7% | 66.0% |
| SYK | $134.44B | 41.8 | 11.2% | 12.9% | 15.1% | 64.0% |
| BSX | — | 49.1 | 19.9% | 14.4% | 12.6% | 69.0% |
| EW | $49.50B | 46.6 | 11.6% | 17.7% | 10.6% | 78.0% |
| BDX | — | 25.3 | 8.2% | 7.7% | 6.5% | — |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| GEHC | — | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 17
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $44.33B | $41.95B | $40.11B | $43.65B | $43.08B | $34.61B | $31.90B | $30.58B | $27.39B | $20.85B | $20.41B | $20.25B | |
| Cost of Revenue | $19.32B | $18.71B | $17.98B | $19.14B | $18.54B | $15.00B | $13.23B | $12.71B | $12.41B | $9.09B | $8.75B | $9.22B | |
| R&D Expense | $2.94B | $2.84B | $2.74B | $2.89B | $2.74B | $2.42B | $2.44B | $2.30B | $2.26B | · | · | · | |
| SG&A Expense | $12.33B | $11.70B | $10.95B | $11.25B | $11.32B | $9.70B | $9.77B | $9.74B | $9.18B | $6.74B | $6.79B | $6.53B | |
| Operating Expenses | $36.27B | $35.12B | $33.63B | $35.29B | $34.65B | $29.25B | $27.37B | $26.93B | $25.83B | $17.83B | $17.54B | $17.65B | |
| Operating Income | $8.05B | $6.83B | $6.48B | $8.36B | $8.43B | $5.36B | $4.53B | $3.65B | $1.56B | $3.03B | $2.87B | $2.60B | |
| Interest Expense | · | · | $637M | $558M | $533M | $546M | $670M | $826M | $904M | $431M | $163M | $150M | |
| Interest Income | $308M | $344M | $385M | $183M | $43M | $46M | $94M | $105M | $124M | $99M | $105M | $77M | |
| Other Non-op | $548M | $376M | $479M | $321M | $277M | $103M | $191M | $139M | $1.41B | $-786M | $281M | $-14M | |
| Pretax Income | $8.47B | $7.01B | $6.66B | $8.31B | $8.21B | $4.97B | $4.08B | $2.87B | $2.23B | $1.41B | $3.18B | $2.52B | |
| Income Tax | $1.94B | $-6.39B | $941M | $1.37B | $1.14B | $497M | $390M | $539M | $1.88B | $350M | $577M | $797M | |
| Net Income | $6.52B | $13.40B | $5.72B | $6.93B | $7.07B | $4.50B | $3.69B | $2.37B | $477M | $1.40B | $4.42B | $2.28B | |
| EPS (Basic) | $3.73 | $7.67 | $3.28 | $3.94 | $3.97 | $2.52 | $2.07 | $1.34 | $0.27 | $0.94 | $2.94 | $1.50 | |
| EPS (Diluted) | $3.72 | $7.64 | $3.26 | $3.91 | $3.94 | $2.50 | $2.06 | $1.33 | $0.27 | $0.94 | $2.92 | $1.49 | |
| Shares (Basic) | 1,741,000,000 | 1,740,000,000 | 1,740,000,000 | 1,753,000,000 | 1,775,000,000 | 1,773,000,000 | 1,768,000,000 | 1,758,000,000 | 1,740,000,000 | 1,477,000,000 | 1,496,000,000 | 1,516,000,000 | |
| Shares (Diluted) | 1,748,000,000 | 1,748,000,000 | 1,749,000,000 | 1,764,000,000 | 1,789,000,000 | 1,786,000,000 | 1,781,000,000 | 1,770,000,000 | 1,749,000,000 | 1,483,000,000 | 1,506,000,000 | 1,527,000,000 | |
| EBITDA | $8.05B | $6.83B | $6.48B | $8.36B | $8.43B | $5.36B | $4.53B | $3.65B | $1.73B | $3.19B | $2.87B | $2.60B |
Balance general 27
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8.52B | $7.62B | $6.90B | $9.88B | $9.80B | $6.84B | $3.86B | $3.84B | $9.41B | $18.62B | $5.00B | $4.06B | |
| Short-term Investments | $417M | $351M | $383M | $288M | $450M | $310M | $280M | $242M | $203M | $155M | $1.12B | $397M | |
| Receivables | $7.93B | $6.92B | $6.57B | $6.22B | $6.49B | $6.41B | $5.42B | $5.18B | $5.25B | $3.25B | $3.42B | $3.59B | |
| Inventory | $6.49B | $6.19B | $6.57B | $6.17B | $5.16B | $5.01B | $4.32B | $3.80B | $3.60B | $2.43B | $2.60B | $2.64B | |
| Other Current Assets | · | · | · | · | · | · | · | · | $1.67B | $1.81B | $1.91B | $1.98B | |
| Current Assets | $26.00B | $23.66B | $22.67B | $25.22B | $24.24B | $20.44B | $15.67B | $14.63B | $20.15B | $26.78B | $14.15B | $13.56B | |
| PP&E (Net) | $11.82B | $10.66B | $10.15B | $9.16B | $8.96B | $9.03B | $8.04B | $7.56B | $7.61B | $5.71B | $5.73B | $5.93B | |
| PP&E (Gross) | $25.22B | $22.74B | $21.93B | $20.21B | $19.36B | $18.79B | $16.80B | $15.71B | $15.27B | $12.37B | $12.38B | $12.63B | |
| Accum. Depreciation | $13.41B | $12.08B | $11.78B | $11.05B | $10.40B | $9.76B | $8.76B | $8.14B | $7.66B | $6.66B | $6.65B | $6.70B | |
| Goodwill | $24.04B | $23.11B | $23.68B | $22.80B | $23.23B | $23.74B | $23.20B | $23.25B | $24.02B | $7.68B | $9.64B | $10.07B | |
| Intangibles | $5.53B | $6.65B | $8.81B | $10.45B | $12.74B | $14.78B | $17.02B | $18.94B | $21.47B | $4.54B | $5.56B | $6.20B | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | $2.12B | $3.29B | |
| Total Assets | $86.71B | $81.41B | $73.21B | $74.44B | $75.20B | $72.55B | $67.89B | $67.17B | $76.25B | $52.67B | $41.25B | $41.21B | |
| Short-term Debt | · | · | · | · | $0 | $213M | $201M | $200M | $206M | $1.32B | $3.13B | $4.38B | |
| Current Liabilities | $16.50B | $14.16B | $13.84B | $15.49B | $13.11B | $11.91B | $10.86B | $9.01B | $8.91B | $6.66B | $9.19B | $10.47B | |
| Capital Leases | $931M | $896M | $949M | $943M | $956M | $902M | $755M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $860M | |
| Other Non-current Liabilities | $2.54B | $2.59B | $3.47B | $3.80B | $3.69B | · | · | · | $9.03B | $4.55B | $4.86B | $5.60B | |
| Long-term Debt | $12.93B | $14.12B | $14.68B | $16.77B | $18.05B | $18.53B | $17.94B | $19.37B | $27.72B | $20.68B | $5.87B | $3.45B | |
| Total Debt | $12.93B | $14.12B | $14.68B | $16.77B | $18.05B | $18.75B | $18.14B | $19.57B | $27.92B | $22.01B | $9.00B | $7.84B | |
| Common Stock | $25.53B | $25.15B | $24.87B | $24.71B | $24.47B | $24.14B | $23.85B | $23.51B | $23.21B | $13.03B | $12.73B | $12.38B | |
| Retained Earnings | $49.78B | $47.26B | $37.55B | $35.26B | $31.53B | $27.63B | $25.85B | $24.56B | $23.98B | $25.57B | $25.76B | $22.87B | |
| Treasury Stock | $17.18B | $16.84B | $15.98B | $15.23B | $11.82B | $10.04B | $10.15B | $9.96B | $10.22B | $10.79B | $10.62B | $8.68B | |
| AOCI | $-6.00B | $-7.91B | $-7.84B | $-8.05B | $-8.37B | $-8.95B | $-8.46B | $-7.59B | $-6.06B | $-7.26B | $-6.66B | $-5.05B | |
| Stockholders' Equity | $52.13B | $47.66B | $38.60B | $36.69B | $35.80B | $32.78B | $31.09B | $30.52B | $30.90B | $20.54B | $21.21B | $21.53B | |
| Liabilities + Equity | $86.71B | $81.41B | $73.21B | $74.44B | $75.20B | $72.55B | $67.89B | $67.17B | $76.25B | $52.67B | $41.25B | $41.21B | |
| Shares Outstanding | 1,996,795,525 | 1,991,472,630 | 1,987,883,852 | 1,986,519,278 | 1,985,273,421 | 1,981,156,896 | 1,976,855,085 | 1,971,189,465 | 1,965,908,188 | 1,707,475,455 | 1,702,017,390 | 1,694,929,949 |
Flujo de Efectivo 17
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $664M | $673M | $644M | $685M | $640M | $546M | $519M | $477M | $406M | $310M | $292M | $246M | |
| Deferred Tax | $441M | $-7.96B | $-461M | $-659M | $-509M | $-108M | $-491M | $745M | $-890M | $-127M | $293M | $302M | |
| Amort. of Intangibles | $1.68B | $1.88B | $1.97B | $2.01B | $2.05B | $2.13B | $1.94B | $2.18B | $1.98B | $550M | $601M | $630M | |
| Restructuring | · | · | · | · | · | $36M | $66M | $28M | · | · | · | · | |
| Operating Cash Flow | $9.57B | $8.56B | $7.26B | $9.58B | $10.53B | $7.90B | $6.14B | $6.30B | $5.57B | $3.20B | $2.97B | $3.67B | |
| CapEx | $2.17B | $2.21B | $2.20B | $1.78B | $1.89B | $2.18B | $1.64B | $1.39B | $1.14B | $1.12B | $1.11B | $1.08B | |
| Investing Cash Flow | $-2.42B | $-2.34B | $-3.13B | $-1.74B | $-2.01B | $-2.21B | $-1.81B | $-1.36B | $-9.62B | $-248M | $406M | $-202M | |
| Debt Issued | · | · | · | · | $4M | $1.28B | $1.84B | $4.01B | $6.74B | $14.93B | $2.48B | · | |
| Net Debt Issued | · | · | · | · | $-44M | $-52M | $-1.60B | $-8.42B | $-1.91B | $14.92B | $2.43B | $-577M | |
| Stock Repurchased | $893M | $1.29B | $1.23B | $3.79B | $2.30B | $403M | $718M | $238M | $117M | $522M | $2.24B | $2.19B | |
| Net Stock Activity | $-893M | $-1.29B | $-1.23B | $-3.79B | $-2.30B | $-403M | $-718M | $-238M | $-117M | $-522M | $-2.24B | $-2.19B | |
| Dividends Paid | $4.12B | $3.84B | $3.56B | $3.31B | $3.20B | $2.56B | $2.27B | $1.97B | $1.85B | $1.54B | $1.44B | $1.34B | |
| Financing Cash Flow | $-6.31B | $-5.40B | $-7.09B | $-7.64B | $-5.49B | $-2.78B | $-4.29B | $-10.39B | $-5.28B | $11.15B | $-2.24B | $-2.74B | |
| Net Change in Cash | $906M | $720M | $-2.99B | $83M | $2.96B | $2.98B | $16M | $-5.56B | $-9.21B | $13.62B | $938M | $588M | |
| Taxes Paid | $1.93B | $1.72B | $1.48B | $1.86B | $1.94B | $970M | $930M | $740M | $570M | $620M | $631M | · | |
| Free Cash Flow | $7.39B | $6.35B | $5.06B | $7.80B | $8.65B | $5.72B | $4.50B | $4.91B | $4.43B | $2.08B | $1.86B | $2.60B | |
| Levered FCF | · | · | $4.51B | $7.34B | $8.19B | $5.23B | $3.89B | $4.23B | $4.29B | $1.76B | $1.72B | $2.50B |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 18.2% | 16.3% | 16.2% | 19.2% | 19.6% | 15.5% | 14.2% | 11.9% | 6.3% | 15.3% | 14.1% | 12.8% | |
| Net Margin | 14.7% | 31.9% | 14.3% | 15.9% | 16.4% | 13.0% | 11.6% | 7.7% | 1.7% | 6.7% | 21.7% | 11.3% | |
| Pretax Margin | 19.1% | 16.7% | 16.6% | 19.0% | 19.1% | 14.4% | 12.8% | 9.4% | 8.2% | 6.8% | 15.6% | 12.4% | |
| EBITDA Margin | 18.2% | 16.3% | 16.2% | 19.2% | 19.6% | 15.5% | 14.2% | 11.9% | 6.3% | 15.3% | 14.1% | 12.8% | |
| ROA | 7.8% | 17.3% | 7.8% | 9.3% | 9.6% | 6.4% | 5.5% | 3.3% | 0.74% | 3.0% | 10.7% | 5.4% | |
| ROE | 13.1% | 31.1% | 15.2% | 19.1% | 20.6% | 14.1% | 12.0% | 7.7% | 1.8% | 6.7% | 20.7% | 9.8% | |
| ROIC | 9.5% | 21.1% | 10.4% | 13.1% | 13.5% | 9.4% | 8.3% | 5.9% | 0.46% | 5.6% | 7.8% | 6.0% |
Liquidez y Solvencia 5
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.7 | 1.6 | 1.6 | 1.8 | 1.7 | 1.4 | 1.6 | 2.3 | 4.0 | 1.5 | 1.4 | |
| Quick Ratio | 1.0 | 1.1 | 1.0 | 1.1 | 1.3 | 1.1 | 0.9 | 1.0 | 1.7 | 3.3 | 1.0 | 0.8 | |
| Debt / Equity | 0.2 | 0.3 | 0.4 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.9 | 1.1 | 0.4 | 0.4 | |
| LT Debt / Equity | 0.2 | 0.3 | 0.4 | 0.4 | 0.5 | 0.6 | 0.5 | 0.6 | 0.9 | 1.0 | 0.3 | 0.2 | |
| Interest Coverage | · | · | 10.2 | 15.0 | 15.8 | 9.8 | 6.8 | 4.4 | 1.9 | 7.4 | 17.6 | 17.3 |
Eficiencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | |
| Inventory Turnover | 3.0 | 2.9 | 2.8 | 3.4 | 3.6 | 3.2 | 3.3 | 3.4 | 4.1 | 3.6 | 3.3 | 3.5 | |
| Receivables Turnover | 6.0 | 6.2 | 6.3 | 6.9 | 6.7 | 5.8 | 6.0 | 5.9 | 6.4 | 6.3 | 5.8 | 5.3 |
Tasas de Crecimiento 10
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 5.7% | 4.6% | -8.1% | 1.3% | 24.5% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 0.51% | -0.88% | 5.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 5.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -51.3% | 134.4% | -16.6% | -0.76% | 57.6% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -1.7% | 24.7% | 9.2% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 8.3% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -51.3% | 134.2% | -17.4% | -1.9% | 57.3% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -2.0% | 23.8% | 8.4% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 7.7% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 10.0% | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 17
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $44.33B | $41.95B | $40.11B | $43.65B | $43.08B | $34.61B | $31.90B | $30.58B | $27.39B | $20.85B | $20.41B | $20.25B | |
| Net Income TTM | $6.52B | $13.40B | $5.72B | $6.93B | $7.07B | $4.50B | $3.69B | $2.37B | $477M | $1.40B | $4.42B | $2.28B | |
| Market Cap | $250.18B | $225.26B | $218.81B | $218.10B | $279.41B | $216.92B | $171.71B | $142.58B | $112.19B | $65.58B | · | · | |
| Enterprise Value | $254.17B | $231.41B | $226.21B | $224.70B | $287.21B | $228.52B | $185.71B | $158.06B | $130.51B | $68.82B | · | · | |
| P/E | 33.7 | 14.8 | 33.8 | 28.1 | 35.7 | 43.8 | 42.2 | 54.4 | 211.4 | 40.9 | 15.4 | 30.2 | |
| P/S | 5.6 | 5.4 | 5.5 | 5.0 | 6.5 | 6.3 | 5.4 | 4.7 | 4.1 | 3.1 | · | · | |
| P/B | 4.8 | 4.7 | 5.7 | 5.9 | 7.8 | 6.6 | 5.5 | 4.7 | 3.6 | 3.2 | · | · | |
| P / Tangible Book | 11.1 | 12.6 | 35.8 | 63.5 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 26.2 | 26.3 | 30.1 | 22.8 | 26.5 | 27.5 | 28.0 | 22.6 | 20.1 | 20.5 | · | · | |
| P / FCF | 33.8 | 35.5 | 43.3 | 27.9 | 32.3 | 37.9 | 38.2 | 29.1 | 25.3 | 31.5 | · | · | |
| EV / EBITDA | 31.6 | 33.9 | 34.9 | 26.9 | 34.1 | 42.7 | 41.0 | 43.3 | 75.6 | 21.6 | · | · | |
| EV / FCF | 34.4 | 36.4 | 44.7 | 28.8 | 33.2 | 39.9 | 41.3 | 32.2 | 29.4 | 33.1 | · | · | |
| EV / Revenue | 5.7 | 5.5 | 5.6 | 5.1 | 6.7 | 6.6 | 5.8 | 5.2 | 4.8 | 3.3 | · | · | |
| Dividend Yield | 1.7% | 1.7% | 1.6% | 1.5% | 1.1% | 1.2% | 1.3% | 1.4% | 1.7% | 2.4% | · | · | |
| Earnings Yield | 3.0% | 6.8% | 3.0% | 3.6% | 2.8% | 2.3% | 2.4% | 1.8% | 0.47% | 2.5% | 6.5% | 3.3% | |
| Payout Ratio | 63.1% | 28.6% | 62.1% | 47.7% | 45.3% | 57.0% | 61.6% | 83.4% | 387.6% | 109.9% | 32.6% | 58.8% | |
| Annual Payout | $4.12B | $3.84B | $3.56B | $3.31B | $3.20B | $2.56B | $2.27B | $1.97B | $1.85B | $1.54B | $1.44B | $1.34B |
Estado de resultados 17
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.59B | $11.16B | $11.46B | $11.37B | $11.14B | $10.36B | $10.97B | $10.63B | $10.38B | $9.96B | $10.24B | $10.14B | $9.98B | $9.75B | $10.09B | $10.41B | |
| Cost of Revenue | $5.33B | $4.89B | $4.92B | $5.08B | $4.85B | $4.47B | $4.94B | $4.70B | $4.60B | $4.46B | $4.56B | $4.61B | $4.48B | $4.33B | $4.59B | $4.63B | |
| R&D Expense | $892M | $767M | $735M | $766M | $725M | $716M | $749M | $713M | $698M | $684M | $700M | $672M | $715M | $654M | $725M | $782M | |
| SG&A Expense | $4.03B | $3.74B | $3.13B | $3.05B | $3.09B | $3.06B | $2.91B | $2.90B | $2.94B | $2.96B | $2.72B | $2.72B | $2.74B | $2.76B | $2.97B | $2.73B | |
| Operating Expenses | $10.90B | $9.82B | $9.21B | $9.31B | $9.09B | $8.66B | $9.06B | $8.78B | $8.71B | $8.58B | $8.46B | $8.50B | $8.44B | $8.24B | $8.79B | $8.64B | |
| Operating Income | $1.69B | $1.34B | $2.25B | $2.06B | $2.05B | $1.69B | $1.91B | $1.86B | $1.67B | $1.39B | $1.78B | $1.65B | $1.54B | $1.51B | $1.30B | $1.77B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $141M | · | $166M | $159M | $153M | · | $141M | |
| Interest Income | $52M | $106M | $78M | $77M | $71M | $82M | $91M | $91M | $82M | $80M | $89M | $97M | $98M | $101M | $88M | $55M | |
| Other Non-op | $134M | $159M | $134M | $150M | $137M | $127M | $154M | $121M | $-10M | $111M | $109M | $83M | $176M | $111M | $68M | $93M | |
| Pretax Income | $1.52B | $1.45B | $2.36B | $2.18B | $2.15B | $1.78B | $2.03B | $1.94B | $1.61B | $1.44B | $1.79B | $1.67B | $1.64B | $1.56B | $1.32B | $1.76B | |
| Income Tax | $596M | $372M | $582M | $536M | $371M | $453M | $-7.20B | $294M | $305M | $211M | $201M | $235M | $261M | $244M | $287M | $323M | |
| Net Income | $928M | $1.08B | $1.78B | $1.64B | $1.78B | $1.32B | $9.23B | $1.65B | $1.30B | $1.23B | $1.59B | $1.44B | $1.38B | $1.32B | $1.03B | $1.44B | |
| EPS (Basic) | $0.53 | $0.62 | $1.01 | $0.94 | $1.02 | $0.76 | $5.29 | $0.94 | $0.74 | $0.70 | $0.92 | $0.82 | $0.79 | $0.75 | $0.59 | $0.82 | |
| EPS (Diluted) | $0.53 | $0.61 | $1.01 | $0.94 | $1.01 | $0.76 | $5.26 | $0.94 | $0.74 | $0.70 | $0.91 | $0.82 | $0.78 | $0.75 | $0.59 | $0.81 | |
| Shares (Basic) | 1,740,420,000 | 1,742,480,000 | -3,483,785,000 | 1,742,142,000 | 1,743,437,000 | 1,739,206,000 | -3,482,709,000 | 1,739,466,000 | 1,743,040,000 | 1,740,203,000 | -3,480,797,000 | 1,738,700,000 | 1,740,359,000 | 1,741,738,000 | -3,515,744,000 | 1,752,968,000 | |
| Shares (Diluted) | 1,742,981,000 | 1,747,073,000 | -3,499,416,000 | 1,749,361,000 | 1,750,835,000 | 1,747,220,000 | -3,500,402,000 | 1,747,597,000 | 1,751,153,000 | 1,749,652,000 | -3,501,252,000 | 1,748,289,000 | 1,750,248,000 | 1,751,715,000 | -3,539,658,000 | 1,763,653,000 | |
| EBITDA | $1.69B | $1.34B | · | $2.06B | $2.05B | $1.69B | · | $1.86B | $1.67B | $1.39B | · | $1.65B | $1.54B | $1.51B | · | $1.77B |
Balance general 23
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5.10B | $6.80B | $8.52B | $7.51B | $6.95B | $6.53B | $7.62B | $7.56B | $6.99B | $6.28B | · | $6.71B | $7.83B | $9.16B | · | $9.59B | |
| Short-term Investments | $499M | $492M | $417M | $222M | $331M | $312M | $351M | $230M | $232M | $367M | · | $338M | $320M | $371M | · | $313M | |
| Receivables | $8.60B | $8.21B | $7.93B | $8.14B | $7.97B | $7.33B | $6.92B | $7.05B | $6.85B | $6.61B | · | $6.50B | $6.17B | $6.02B | · | $6.41B | |
| Inventory | $7.32B | $6.99B | $6.49B | $6.71B | $6.95B | $6.64B | $6.19B | $6.81B | $6.81B | $6.83B | · | $6.65B | $6.87B | $6.67B | · | $5.73B | |
| Current Assets | $24.52B | $25.51B | $26.00B | $24.84B | $24.47B | $23.15B | $23.66B | $23.80B | $23.12B | $22.38B | · | $22.66B | $23.50B | $24.38B | · | $24.84B | |
| PP&E (Net) | $12.81B | $12.38B | $11.82B | $11.50B | $11.39B | $10.93B | $10.66B | $10.62B | $10.23B | $10.11B | · | $9.55B | $9.45B | $9.28B | · | $8.69B | |
| PP&E (Gross) | $26.47B | $25.74B | $25.22B | $24.82B | $24.47B | $23.42B | $22.74B | $22.86B | $22.06B | $22.05B | · | $21.11B | $20.93B | $20.61B | · | $19.31B | |
| Accum. Depreciation | $13.66B | $13.36B | $13.41B | $13.31B | $13.08B | $12.49B | $12.08B | $12.24B | $11.83B | $11.95B | · | $11.56B | $11.48B | $11.32B | · | $10.62B | |
| Goodwill | $35.24B | $35.22B | $24.04B | $23.97B | $23.95B | $23.36B | $23.11B | $23.66B | $23.31B | $23.38B | · | $23.28B | $23.26B | $22.93B | · | $22.28B | |
| Intangibles | $17.21B | $17.88B | $5.53B | $5.60B | $5.92B | $6.26B | $6.65B | $7.35B | $7.83B | $8.30B | · | $9.28B | $9.83B | $10.01B | · | $10.85B | |
| Total Assets | $109.22B | $110.43B | $86.71B | $84.18B | $84.00B | $81.45B | $81.41B | $74.36B | $73.02B | $72.47B | · | $72.09B | $73.35B | $73.79B | · | $72.80B | |
| Current Liabilities | $17.81B | $18.38B | $16.50B | $14.58B | $13.44B | $13.00B | $14.16B | $14.90B | $13.76B | $14.02B | · | $13.04B | $14.35B | $14.53B | · | $13.37B | |
| Capital Leases | · | · | $931M | · | · | · | $896M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | $2.54B | · | · | · | $2.59B | · | · | · | · | · | · | · | · | · | |
| Long-term Debt | $32.61B | $34.05B | $12.93B | $12.94B | $13.44B | $13.24B | $14.12B | $14.98B | $14.75B | $14.59B | · | $15.53B | $16.85B | $16.90B | · | $16.41B | |
| Total Debt | $32.61B | $34.05B | · | $12.94B | $13.44B | $13.24B | · | $14.98B | $14.75B | $14.59B | · | $15.53B | $16.85B | $16.90B | · | $16.41B | |
| Common Stock | $25.50B | $25.35B | $25.53B | $25.41B | $25.28B | $25.12B | $25.15B | $25.02B | $24.86B | $24.73B | · | $24.73B | $24.61B | $24.49B | · | $24.56B | |
| Retained Earnings | $49.79B | $49.96B | $49.78B | $49.10B | $48.47B | $47.72B | $47.26B | $39.06B | $38.35B | $38.01B | · | $36.92B | $36.35B | $35.87B | · | $35.12B | |
| Treasury Stock | $17.97B | $16.93B | $17.18B | $16.88B | $16.61B | $16.61B | $16.84B | $16.48B | $15.76B | $15.76B | · | $15.69B | $15.72B | $15.31B | · | $14.55B | |
| AOCI | $-6.21B | $-6.31B | $-6.00B | $-6.68B | $-6.58B | $-7.42B | $-7.91B | $-7.80B | $-8.13B | $-8.17B | $-7.84B | $-8.48B | $-8.07B | $-8.04B | $-8.05B | $-9.45B | |
| Stockholders' Equity | $51.11B | $52.06B | $52.13B | $50.95B | $50.56B | $48.81B | $47.66B | $39.80B | $39.32B | $38.81B | · | $37.48B | $37.17B | $37.01B | · | $35.67B | |
| Liabilities + Equity | $109.22B | $110.43B | $86.71B | $84.18B | $84.00B | $81.45B | $81.41B | $74.36B | $73.02B | $72.47B | · | $72.09B | $73.35B | $73.79B | · | $72.80B | |
| Shares Outstanding | 1,998,291,279 | 1,998,233,756 | 1,996,795,525 | 1,996,743,794 | 1,996,448,469 | 1,995,858,606 | 1,991,472,630 | 1,991,051,414 | 1,990,029,292 | 1,989,789,999 | 1,987,883,852 | 1,987,305,154 | 1,987,181,491 | 1,986,904,170 | 1,986,519,278 | 1,985,919,440 |
Flujo de Efectivo 14
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $168M | $317M | $113M | $120M | $142M | $289M | $111M | $117M | $141M | $304M | $114M | $117M | $132M | $281M | $115M | $123M | |
| Amort. of Intangibles | $658M | $422M | $422M | $420M | $420M | $420M | $465M | $470M | $471M | $472M | $481M | $496M | $498M | $491M | $496M | $498M | |
| Operating Cash Flow | $2.49B | $1.31B | $3.31B | $2.79B | $2.05B | $1.42B | $2.87B | $2.71B | $1.96B | $1.02B | $3.04B | $1.88B | $1.20B | $1.14B | $2.33B | $2.78B | |
| CapEx | $497M | $399M | $689M | $496M | $502M | $484M | $720M | $556M | $533M | $398M | $755M | $560M | $507M | $380M | $610M | $467M | |
| Investing Cash Flow | $-673M | $-20.32B | $-913M | $-457M | $-582M | $-470M | $-866M | $-594M | $-453M | $-425M | $-824M | $-634M | $-1.21B | $-462M | $-632M | $-484M | |
| Debt Issued | $-33M | $19.86B | · | $0 | $2M | $1M | · | $1M | $221M | $0 | · | $0 | · | · | · | $1M | |
| Net Debt Issued | · | $18.44B | · | · | · | $-1.00B | · | · | · | · | · | · | · | $0 | · | · | |
| Stock Repurchased | $1.04B | $180M | $302M | $305M | $6M | $280M | $315M | $751M | $3M | $226M | $259M | $2M | $426M | $540M | $685M | $798M | |
| Net Stock Activity | · | $-180M | · | · | · | $-280M | · | · | · | $-226M | · | · | · | $-540M | · | · | |
| Dividends Paid | $1.10B | $1.10B | $1.03B | $1.03B | $1.03B | $1.03B | $958M | $960M | $961M | $957M | $888M | $888M | $890M | $890M | $823M | $826M | |
| Financing Cash Flow | $-3.52B | $17.31B | $-1.40B | $-1.76B | $-1.10B | $-2.06B | $-1.86B | $-1.58B | $-791M | $-1.18B | $-2.05B | $-2.34B | $-1.29B | $-1.41B | $-1.46B | $-1.54B | |
| Net Change in Cash | $-1.70B | $-1.72B | $1.01B | $560M | $419M | $-1.08B | $58M | $571M | $703M | $-612M | $187M | $-1.13B | $-1.33B | $-721M | $288M | $657M | |
| Free Cash Flow | · | $916M | · | · | · | $933M | · | · | · | $627M | · | · | · | $763M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $507M | · | · | · | $634M | · | · |
Rentabilidad 7
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 13.4% | 12.0% | · | 18.1% | 18.4% | 16.3% | · | 17.5% | 16.1% | 13.9% | · | 16.2% | 15.4% | 15.5% | · | 17.0% | |
| Net Margin | 7.4% | 9.7% | · | 14.5% | 16.0% | 12.8% | · | 15.5% | 12.6% | 12.3% | · | 14.2% | 13.8% | 13.5% | · | 13.8% | |
| Pretax Margin | 12.1% | 13.0% | · | 19.2% | 19.3% | 17.2% | · | 18.2% | 15.5% | 14.4% | · | 16.5% | 16.4% | 16.0% | · | 16.9% | |
| EBITDA Margin | 13.4% | 12.0% | · | 18.1% | 18.4% | 16.3% | · | 17.5% | 16.1% | 13.9% | · | 16.2% | 15.4% | 15.5% | · | 17.0% | |
| ROA | 0.96% | 1.1% | · | 2.1% | 2.3% | 1.7% | · | 2.2% | 1.8% | 1.7% | · | 2.0% | 1.9% | 1.8% | · | 2.0% | |
| ROE | 1.8% | 2.1% | · | 3.6% | 4.0% | 3.0% | · | 4.3% | 3.4% | 3.2% | · | 3.9% | 3.7% | 3.6% | · | 4.1% | |
| ROIC | 1.2% | 1.2% | · | 2.4% | 2.6% | 2.0% | · | 2.9% | 2.5% | 2.2% | · | 2.7% | 2.4% | 2.4% | · | 2.8% |
Liquidez y Solvencia 5
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | · | 1.7 | 1.8 | 1.8 | · | 1.6 | 1.7 | 1.6 | · | 1.7 | 1.6 | 1.7 | · | 1.9 | |
| Quick Ratio | 0.8 | 0.8 | · | 1.1 | 1.1 | 1.1 | · | 1.0 | 1.0 | 0.9 | · | 1.0 | 1.0 | 1.1 | · | 1.2 | |
| Debt / Equity | 0.6 | 0.7 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.5 | |
| LT Debt / Equity | 0.6 | 0.6 | · | 0.2 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 9.8 | · | 9.9 | 9.7 | 9.9 | · | 12.6 |
Eficiencia 3
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.7 | 0.7 | · | 0.8 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.8 | |
| Receivables Turnover | 1.5 | 1.4 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.6 | · | 1.6 | 1.5 | 1.5 | · | 1.6 |
Valoración (TTM) 15
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $46.27B | $44.03B | · | $43.50B | $42.51B | $41.33B | · | $41.12B | $40.46B | $39.83B | · | $40.28B | $41.39B | $43.31B | · | $44.49B | |
| Net Income TTM | $5.43B | $5.83B | · | $6.39B | $6.05B | $5.50B | · | $5.61B | $5.34B | $5.35B | · | $5.56B | $6.15B | $7.22B | · | $8.00B | |
| Market Cap | $181.32B | $205.16B | · | $267.44B | $271.54B | $264.75B | · | $227.00B | $206.78B | $226.16B | · | $192.47B | $216.64B | $201.19B | · | $192.16B | |
| Enterprise Value | $208.33B | $231.91B | · | $272.65B | $277.69B | $271.15B | · | $234.19B | $214.32B | $234.09B | · | $200.95B | $225.33B | $208.56B | · | $198.66B | |
| P/E | 29.4 | 30.9 | · | 36.7 | 39.4 | 42.2 | · | 35.6 | 34.2 | 37.3 | · | 30.6 | 31.3 | 24.9 | · | 21.6 | |
| P/S | 3.9 | 4.7 | · | 6.1 | 6.4 | 6.4 | · | 5.5 | 5.1 | 5.7 | · | 4.8 | 5.2 | 4.6 | · | 4.3 | |
| P/B | 3.5 | 3.9 | · | 5.2 | 5.4 | 5.4 | · | 5.7 | 5.3 | 5.8 | · | 5.1 | 5.8 | 5.4 | · | 5.4 | |
| P / Tangible Book | · | · | · | 12.5 | 13.1 | 13.8 | · | 25.8 | 25.3 | 31.7 | · | 39.1 | 53.1 | 49.3 | · | 75.6 | |
| P / Cash Flow | · | 156.0 | · | · | · | 186.8 | · | · | · | 220.6 | · | · | · | 176.0 | · | · | |
| P / FCF | · | 224.0 | · | · | · | 283.8 | · | · | · | 360.7 | · | · | · | 263.7 | · | · | |
| EV / EBITDA | 123.1 | 172.4 | · | 132.5 | 135.3 | 160.2 | · | 126.0 | 128.4 | 168.9 | · | 122.0 | 146.1 | 138.2 | · | 112.2 | |
| EV / FCF | · | 253.2 | · | · | · | 290.6 | · | · | · | 373.4 | · | · | · | 273.3 | · | · | |
| EV / Revenue | 4.5 | 5.3 | · | 6.3 | 6.5 | 6.6 | · | 5.7 | 5.3 | 5.9 | · | 5.0 | 5.4 | 4.8 | · | 4.5 | |
| Earnings Yield | 3.4% | 3.2% | · | 2.7% | 2.5% | 2.4% | · | 2.8% | 2.9% | 2.7% | · | 3.3% | 3.2% | 4.0% | · | 4.6% | |
| Payout Ratio | · | 102.0% | · | · | · | 77.4% | · | · | · | 78.1% | · | · | · | 67.5% | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $44.33B | $41.95B | $40.11B | $43.65B | $43.08B |
| Margen Operativo % | 18.2% | 16.3% | 16.2% | 19.2% | 19.6% |
| Beneficio neto | $6.52B | $13.40B | $5.72B | $6.93B | $7.07B |
| EPS Diluido | $3.72 | $7.64 | $3.26 | $3.91 | $3.94 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 0.2 | 0.3 | 0.4 | 0.5 | 0.5 |
| Ratio corriente | 1.6 | 1.7 | 1.6 | 1.6 | 1.8 |
| Ratio Rápido | 1.0 | 1.1 | 1.0 | 1.1 | 1.3 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $7.39B | $6.35B | $5.06B | $7.80B | $8.65B |
Últimas noticias Noticias recientes que mencionan a esta empresa
- Abbott raises 2026 profit forecast on strength in diagnostics, heart devices
- Why Abbott Stock Jumped Today
- Is Abbott (ABT) the Best Longevity Stock to Buy Now?
- This is Why Abbott Laboratories (ABT) is One of the Best Deep Value Stock to Invest In
- 2 Acciones de Dividendos para Comprar y Mantener Para Siempre
- Las acciones de Abbott cotizan a mínimos de 52 semanas, pero los insiders están acaparando acciones de este pagador de dividendos de primer nivel
- ¿Quiere Ingresos Dividendo Confiables en Mayo? Estas 2 Acciones lo Ofrecen
- El rendimiento de este Dividend King no ha sido tan alto en una década. ¿Es una compra?
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 3 307 declarantes · $77.5B total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 167 (-58 vs trimestre anterior) | 264 (-26 vs trimestre anterior) | 1 074 (-57 vs trimestre anterior) | 1 358 (-40 vs trimestre anterior) | -26.3M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $10 321 765 196 | 113 750 994 | 13,32% | Acciones |
| STATE STREET CORP | $7 343 246 473 | 80 926 234 | 9,48% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $4 447 881 161 | 49 017 866 | 5,74% | Acciones |
| Capital Research Global Investors | $3 349 205 208 | 36 908 990 | 4,32% | Acciones |
| Capital International Investors | $3 146 147 651 | 34 654 113 | 4,06% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $3 021 806 516 | 33 484 908 | 3,90% | Acciones |
| NORGES BANK | $2 119 224 624 | 23 354 911 | 2,73% | Acciones |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $988 809 932 | 10 897 178 | 1,28% | Acciones |
| FLOSSBACH VON STORCH SE | $902 938 133 | 9 950 828 | 1,17% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $887 350 453 | 9 779 044 | 1,14% | Acciones |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | $873 572 128 | 9 627 200 | 1,13% | Acciones |
| Grantham, Mayo, Van Otterloo & Co. LLC | $797 974 712 | 8 794 077 | 1,03% | Acciones |
| JANUS HENDERSON GROUP PLC | $780 800 730 | 7 604 955 | 1,01% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $737 381 823 | 8 126 315 | 0,95% | Acciones |
| CITADEL ADVISORS LLC | $732 793 646 | 8 075 751 | 0,95% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $724 904 438 | 7 988 808 | 0,94% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $694 247 236 | 7 650 948 | 0,90% | Acciones |
| GOLDMAN SACHS GROUP INC | $579 394 142 | 6 385 212 | 0,75% | Acciones |
| BlackRock, Inc. | $551 881 406 | 6 082 008 | 0,71% | Acciones |
| AMERIPRISE FINANCIAL INC | $547 727 798 | 6 035 539 | 0,71% | Acciones |
| BANK OF AMERICA CORP /DE/ | $535 831 639 | 5 905 132 | 0,69% | Acciones |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $487 309 824 | 5 370 397 | 0,63% | Acciones |
| FMR LLC | $477 936 254 | 5 267 096 | 0,62% | Acciones |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $447 962 873 | 4 936 774 | 0,58% | Acciones |
| Swiss National Bank | $445 749 361 | 4 912 380 | 0,58% | Acciones |
| Mitsubishi UFJ Asset Management Co., Ltd. | $390 471 098 | 4 303 186 | 0,50% | Acciones |
| National Pension Service | $381 876 296 | 4 208 467 | 0,49% | Acciones |
| ENVESTNET ASSET MANAGEMENT INC | $359 002 790 | 3 956 395 | 0,46% | Acciones |
| Legal & General Group Plc | $356 621 537 | 3 930 147 | 0,46% | Acciones |
| Vanguard Global Advisers, LLC | $356 401 041 | 3 927 717 | 0,46% | Acciones |
| Sumitomo Mitsui Trust Group, Inc. | $356 221 103 | 3 925 734 | 0,46% | Acciones |
| VANGUARD ASSET MANAGEMENT, Ltd | $355 855 239 | 3 921 702 | 0,46% | Acciones |
| VANGUARD GROUP INC | $352 398 046 | 2 812 659 | 0,45% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $326 663 456 | 3 599 994 | 0,42% | Acciones |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $324 048 420 | 3 571 175 | 0,42% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $307 912 464 | 2 999 050 | 0,40% | Acciones |
| UBS Group AG | $302 485 873 | 3 333 545 | 0,39% | Acciones |
| PRINCIPAL FINANCIAL GROUP INC | $295 969 379 | 3 261 730 | 0,38% | Acciones |
| Assenagon Asset Management S.A. | $292 053 223 | 3 218 572 | 0,38% | Acciones |
| JARISLOWSKY, FRASER Ltd | $289 054 440 | 2 158 089 | 0,37% | Acciones |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | $283 562 500 | 3 125 000 | 0,37% | Acciones |
| Rathbones Group PLC | $279 003 540 | 3 074 758 | 0,36% | Acciones |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $274 648 102 | 2 675 057 | 0,35% | Acciones |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $262 660 558 | 2 558 299 | 0,34% | Acciones |
| STOREBRAND ASSET MANAGEMENT AS | $259 462 863 | 2 859 410 | 0,33% | Acciones |
| PNC Financial Services Group, Inc. | $257 810 942 | 2 841 205 | 0,33% | Acciones |
| RHUMBLINE ADVISERS | $255 936 973 | 2 820 543 | 0,33% | Acciones |
| UBS Group AG | $250 750 916 | 2 763 400 | 0,32% | Opción de venta |
| RAYMOND JAMES FINANCIAL INC | $245 980 061 | 2 710 823 | 0,32% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $239 769 108 | 2 642 375 | 0,31% | Acciones |
| 1832 Asset Management L.P. | $237 351 068 | 2 615 727 | 0,31% | Acciones |
| CITADEL ADVISORS LLC | $234 272 532 | 2 581 800 | 0,30% | Opción de compra |
| CANADA PENSION PLAN INVESTMENT BOARD | $230 891 469 | 2 544 539 | 0,30% | Acciones |
| Holocene Advisors, LP | $226 003 396 | 2 490 670 | 0,29% | Acciones |
| Ninety One UK Ltd | $225 389 076 | 2 483 900 | 0,29% | Acciones |
| NEUBERGER BERMAN GROUP LLC | $223 999 839 | 2 467 027 | 0,29% | Acciones |
| Ensign Peak Advisors, Inc | $216 085 151 | 2 381 366 | 0,28% | Acciones |
| JANE STREET GROUP, LLC | $213 973 994 | 2 358 100 | 0,28% | Opción de compra |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $211 616 115 | 2 332 115 | 0,27% | Acciones |
| LPL Financial LLC | $205 718 613 | 2 267 122 | 0,27% | Acciones |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $201 807 847 | 2 224 023 | 0,26% | Acciones |
| BARCLAYS PLC | $200 112 461 | 2 205 339 | 0,26% | Acciones |
| Qube Research & Technologies Ltd | $194 357 367 | 2 141 915 | 0,25% | Acciones |
| California Public Employees Retirement System | $194 024 624 | 2 138 248 | 0,25% | Acciones |
| Nuveen Asset Management, LLC | $192 921 092 | 1 705 606 | 0,25% | Acciones |
| PeakShares LLC | $184 202 000 | 2 030 | 0,24% | Acciones |
| Fayez Sarofim & Co | $183 924 904 | 2 026 944 | 0,24% | Acciones |
| ProShare Advisors LLC | $182 849 174 | 2 015 089 | 0,24% | Acciones |
| Mirae Asset Global Investments Co., Ltd. | $171 498 419 | 1 889 998 | 0,22% | Acciones |
| NEW YORK STATE COMMON RETIREMENT FUND | $171 110 051 | 1 885 718 | 0,22% | Acciones |
| US BANCORP \DE\ | $169 625 636 | 1 869 359 | 0,22% | Acciones |
| DAVENPORT & Co LLC | $166 731 901 | 1 827 013 | 0,22% | Acciones |
| Nuveen, LLC | $165 441 322 | 1 823 246 | 0,21% | Acciones |
| Focus Partners Wealth | $159 171 295 | 1 753 727 | 0,21% | Acciones |
| LOCUST WOOD CAPITAL ADVISERS, LLC | $156 227 543 | 1 721 705 | 0,20% | Acciones |
| FIFTH THIRD BANCORP | $155 739 304 | 1 716 325 | 0,20% | Acciones |
| Alecta Tjanstepension Omsesidigt | $145 922 256 | 1 609 200 | 0,19% | Acciones |
| Hudson Bay Capital Management LP | $145 184 000 | 1 600 000 | 0,19% | Acciones |
| Mizuho Markets Cayman LP | $144 086 409 | 1 587 904 | 0,19% | Acciones |
| HighTower Advisors, LLC | $143 884 700 | 1 585 681 | 0,19% | Acciones |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | $141 332 725 | 1 557 555 | 0,18% | Acciones |
| Point72 Asset Management, L.P. | $140 822 037 | 1 551 929 | 0,18% | Acciones |
| MACKENZIE FINANCIAL CORP | $140 782 112 | 1 551 489 | 0,18% | Acciones |
| GOLDMAN SACHS GROUP INC | $139 367 566 | 1 535 900 | 0,18% | Opción de compra |
| AVIVA PLC | $138 734 382 | 1 528 922 | 0,18% | Acciones |
| Hudson Bay Capital Management LP | $136 110 000 | 1 500 000 | 0,18% | Opción de venta |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $134 754 435 | 1 485 061 | 0,17% | Acciones |
| EVERETT HARRIS & CO /CA/ | $131 785 524 | 1 452 342 | 0,17% | Acciones |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $130 414 419 | 1 432 081 | 0,17% | Acciones |
| TD Asset Management Inc | $129 183 362 | 1 423 665 | 0,17% | Acciones |
| Vestal Point Capital, LP | $127 036 000 | 1 400 000 | 0,16% | Acciones |
| Bank Julius Baer & Co. Ltd, Zurich | $126 054 316 | 1 387 458 | 0,16% | Acciones |
| Freestone Grove Partners LP | $124 572 046 | 1 372 846 | 0,16% | Acciones |
| Public Sector Pension Investment Board | $124 551 992 | 1 372 625 | 0,16% | Acciones |
| Eurizon Capital SGR S.p.A. | $121 802 182 | 1 335 277 | 0,16% | Acciones |
| M&G PLC | $120 614 949 | 1 325 439 | 0,16% | Acciones |
| ING GROEP NV | $119 814 457 | 1 320 415 | 0,15% | Acciones |
| MARSHALL WACE, LLP | $119 044 891 | 1 311 934 | 0,15% | Acciones |
| Baird Financial Group, Inc. | $116 820 060 | 1 287 415 | 0,15% | Acciones |
| PRUDENTIAL FINANCIAL INC | $115 655 480 | 1 274 581 | 0,15% | Acciones |
Informantes de la empresa 110 insiders · 75 directivos · 32 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Robert B Ford | CHAIRMAN AND CEO | 28 de febrero de 2025 F | 253 305 | 0 | 0 | $0 |
| Philip P Boudreau | EVP AND CFO | 1 de septiembre de 2025 F | 50 616 | 0 | 0 | $0 |
| Brian B Yoor | Executive Vice President & CFO | 28 de febrero de 2020 F | 114 099 | 0 | 0 | $0 |
| Jeffrey M Leiden | President and COO | 24 de marzo de 2006 D | 209 401 | 0 | 0 | $0 |
| Elizabeth C. Cushman | EVP, GC AND SECRETARY | 27 de junio de 2026 F | 38 013 | 0 | 0 | $0 |
| John A. Mccoy JR. | VICE PRESIDENT AND CONTROLLER | 1 de septiembre de 2025 F | 20 982 | 0 | 0 | $0 |
| Lisa D Earnhardt | EVP AND GROUP PRESIDENT | 7 de marzo de 2025 M | 71 928 | 0 | 0 | $0 |
| Eric Shroff | Senior Vice President | 3 de marzo de 2025 S | 31 970 | 0 | 0 | $0 |
| Mary K Moreland | EXECUTIVE VICE PRESIDENT | 3 de marzo de 2025 S | 95 583 | 0 | 0 | $0 |
| Andrea F Wainer | RETIRED EVP | 3 de marzo de 2025 S | 74 381 | 0 | 0 | $0 |
| Daniel Gesua Sive Salvadori | EVP AND GROUP PRESIDENT | 28 de febrero de 2025 F | 133 769 | 0 | 0 | $0 |
| Hubert L Allen | EXECUTIVE VICE PRESIDENT, GC | 28 de febrero de 2025 F | 191 899 | 0 | 0 | $0 |
| Robert E Funck | EXECUTIVE VICE PRESIDENT | 10 de mayo de 2024 M | 211 341 | 0 | 0 | $0 |
| Julie L. Tyler | SENIOR VICE PRESIDENT | 1 de marzo de 2023 S | 39 162 | 0 | 0 | $0 |
| Gregory A Ahlberg | SENIOR VICE PRESIDENT | 1 de marzo de 2023 S | 38 420 | 0 | 0 | $0 |
| John F Ginascol | EXECUTIVE VICE PRESIDENT | 1 de marzo de 2023 S | 118 380 | 0 | 0 | $0 |
| Joseph J Manning | EXECUTIVE VICE PRESIDENT | 1 de marzo de 2023 S | 62 323 | 0 | 0 | $0 |
| Jared Watkin | SENIOR VICE PRESIDENT | 1 de marzo de 2023 S | 71 366 | 0 | 0 | $0 |
| Randel William Woodgrift | SENIOR VICE PRESIDENT | 1 de marzo de 2023 S | 52 203 | 0 | 0 | $0 |
| DALE MICHAEL D | SENIOR VICE PRESIDENT | 1 de marzo de 2023 S | 45 133 | 0 | 0 | $0 |
| Fernando Mateus | SENIOR VICE PRESIDENT | 28 de febrero de 2023 F | 22 857 | 0 | 0 | $0 |
| Christopher J. Calamari | SENIOR VICE PRESIDENT | 28 de febrero de 2023 F | 32 822 | 0 | 0 | $0 |
| Sammy Karam | SENIOR VICE PRESIDENT | 28 de febrero de 2023 F | 38 092 | 0 | 0 | $0 |
| Alejandro D Wellisch | SENIOR VICE PRESIDENT | 28 de febrero de 2023 F | 46 752 | 0 | 0 | $0 |
| Michael J Pederson | SENIOR VICE PRESIDENT | 28 de febrero de 2023 F | 63 156 | 0 | 0 | $0 |
| John M Capek | EXECUTIVE VICE PRESIDENT | 28 de febrero de 2023 F | 339 443 | 0 | 0 | $0 |
| Andrew H Lane | EXECUTIVE VICE PRESIDENT | 15 de noviembre de 2021 S | 76 087 | 0 | 0 | $0 |
| Miles D White | EXECUTIVE CHAIRMAN | 12 de noviembre de 2021 G | 3 092 852 | 0 | 0 | $0 |
| Roger Bird | SENIOR VICE PRESIDENT | 27 de abril de 2021 S | 51 083 | 0 | 0 | $0 |
| Christopher J Scoggins | SENIOR VICE PRESIDENT | 1 de abril de 2021 F | 46 121 | 0 | 0 | $0 |
| Charles Brynelsen | SENIOR VICE PRESIDENT | 1 de marzo de 2021 S | 43 550 | 0 | 0 | $0 |
| Jaime Contreras | Senior Vice President | 21 de abril de 2020 M | 62 205 | 0 | 0 | $0 |
| Brian J Blaser | Executive Vice President | 23 de mayo de 2019 M | 130 745 | 0 | 0 | $0 |
| Stephen R Fussell | Executive Vice President | 23 de abril de 2019 M | 169 935 | 0 | 0 | $0 |
| Sharon J Bracken | Senior Vice President | 31 de marzo de 2019 D | 5 936 | 0 | 0 | $0 |
| Sean Shrimpton | Senior Vice President | 31 de diciembre de 2018 F | 16 165 | 0 | 0 | $0 |
| Eric S Fain | Senior Vice President | 21 de julio de 2017 D | 493 961 | 0 | 0 | $0 |
| Michael T Rousseau | Pres., Cardiovas. & Neuromod. | 7 de julio de 2017 F | 183 116 | 0 | 0 | $0 |
| Heather L Mason | Executive Vice President | 1 de julio de 2017 F | 59 064 | 0 | 0 | $0 |
| Michael J Warmuth | Executive Vice President | 1 de marzo de 2017 S | 56 508 | 0 | 0 | $0 |
| Jean-Yves Pavee | Senior Vice President | 1 de julio de 2016 F | 36 861 | 0 | 0 | $0 |
| Richard W Ashley | Executive Vice President | 29 de febrero de 2016 S | 354 517 | 0 | 0 | $0 |
| Thomas G Frinzi | Senior Vice President | 19 de febrero de 2016 A | 31 921 | 0 | 0 | $0 |
| Charles D Foltz | Senior Vice President | 1 de abril de 2015 F | 93 333 | 0 | 0 | $0 |
| Scott J. White | Senior Vice President | 26 de marzo de 2015 M | 95 719 | 0 | 0 | $0 |
| Georges H. Devos | Senior Vice President | 27 de febrero de 2015 A | 12 129 | 0 | 0 | $0 |
| Murthy V Simhambhatla | Senior Vice President | 27 de febrero de 2015 F | 57 575 | 0 | 0 | $0 |
| John C Landgraf | Executive Vice President | 27 de febrero de 2015 F | 108 972 | 0 | 0 | $0 |
| Katherine C. Doyle | Senior Vice President | 15 de abril de 2014 S | 43 474 | 0 | 0 | $0 |
| David A. Forrest | Senior Vice President | 17 de septiembre de 2013 F | 42 013 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 11 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| [Entities Only] Abbott Laboratories (, Abbott Products, Abbott Investments Luxembourg S.à r.l. ×6 presentaciones | 24 de marzo de 2017 | — | Presentación inicial | — | SEC |
| Abbott Laboratories, Amber Acquisition Inc. ×13 presentaciones | 21 de abril de 2010 | — | Presentación inicial | M&A / venta | SEC |
| Abbott Laboratories IRS Identification No. ×11 presentaciones | 16 de diciembre de 2004 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 22 de enero de 2004 | — | Presentación inicial | M&A / venta | SEC |
| S. OR | 8 de agosto de 2002 | — | Presentación inicial | — | SEC |
| Abbott Laboratories ( | 7 de marzo de 2002 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 1 de noviembre de 2001 | — | Presentación inicial | M&A / venta | SEC |
| Persona informante no revelada | 24 de mayo de 2001 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 17 de abril de 2001 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 7 de marzo de 2001 | — | Presentación inicial | — | SEC |
| Persona informante no revelada | 16 de febrero de 2001 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 223 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IHI · iShares Trust | 19,02% | 5 737 319 SH | 21 de agosto de 2026 | Diario |
| PJP · Invesco Exchange-Traded Fund Trust | 5,77% | 267 267 SH | 21 de agosto de 2026 | Diario |
| IYH · iShares Trust | 3,05% | 1 033 684 SH | 21 de agosto de 2026 | Diario |
| SCHD · SCHWAB STRATEGIC TRUST | 2,96% | 32 820 222 NS | 31 de mayo de 2026 | N-PORT |
| CWS · AdvisorShares Trust | 2,95% | 43 046 NS | 30 de junio de 2026 | N-PORT |
| HRTS · Tema ETF Trust | 2,61% | 15 809 NS | 31 de mayo de 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 2,55% | 801 594 NS | 30 de abril de 2026 | N-PORT |
| IXJ · iShares Trust | 2,40% | 915 890 SH | 21 de agosto de 2026 | Diario |
| HDV · iShares Trust | 2,39% | 3 218 623 SH | 21 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 2,33% | 5 235 711 SH | 19 de agosto de 2026 | Diario |
| QLTY · GMO ETF Trust | 2,29% | 1 204 586 NS | 31 de mayo de 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 2,28% | 34 673 NS | 30 de abril de 2026 | N-PORT |
| RXL · ProShares Trust | 2,15% | 18 132 NS | 31 de mayo de 2026 | N-PORT |
| QUSA · Tidal Trust III | 2,14% | 4 173 NS | 30 de abril de 2026 | N-PORT |
| FDIV · EA Series Trust | 1,95% | 15 623 NS | 30 de abril de 2026 | N-PORT |
| PRVS · Parnassus Funds II | 1,94% | 5 401 NS | 30 de junio de 2026 | N-PORT |
| OUSA · ALPS ETF Trust | 1,92% | 166 396 NS | 31 de mayo de 2026 | N-PORT |
| MDEV · First Trust Exchange-Traded Fund VI | 1,85% | 392 NS | 30 de junio de 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,85% | 133 006 SH | 21 de agosto de 2026 | Diario |
| JGRW · Trust for Professional Managers | 1,77% | 19 858 NS | 31 de mayo de 2026 | N-PORT |
| PEXL · Pacer Funds Trust | 1,48% | 7 452 NS | 30 de abril de 2026 | N-PORT |
| KNG · First Trust Exchange-Traded Fund IV | 1,42% | 528 786 NS | 30 de abril de 2026 | N-PORT |
| MFSV · MFS Active Exchange Traded Funds Tr… | 1,41% | 78 110 NS | 31 de mayo de 2026 | N-PORT |
| SPXD · DBX ETF Trust | 1,37% | 1 082 NS | 31 de mayo de 2026 | N-PORT |
| NOBL · ProShares Trust | 1,35% | 1 749 432 NS | 31 de mayo de 2026 | N-PORT |
| ANEW · ProShares Trust | 1,32% | 1 196 NS | 31 de mayo de 2026 | N-PORT |
| VALQ · AMERICAN CENTURY ETF TRUST | 1,24% | 50 554 NS | 31 de mayo de 2026 | N-PORT |
| TMDV · ProShares Trust | 1,23% | 633 NS | 31 de mayo de 2026 | N-PORT |
| EQWL · Invesco Exchange-Traded Fund Trust | 1,21% | 296 845 SH | 21 de agosto de 2026 | Diario |
| DGRO · iShares Trust | 1,17% | 4 472 407 SH | 21 de agosto de 2026 | Diario |
| SHRY · First Trust Exchange-Traded Fund VI | 1,07% | 1 770 NS | 30 de junio de 2026 | N-PORT |
| SNPV · DBX ETF Trust | 1,01% | 27 271 NS | 29 de mayo de 2026 | N-PORT |
| QIDX · Spinnaker ETF Series | 1,01% | 4 283 NS | 30 de abril de 2026 | N-PORT |
| CGCV · Capital Group Conservative Equity E… | 1,00% | 205 102 NS | 31 de mayo de 2026 | N-PORT |
| RDVI · First Trust Exchange-Traded Fund IV | 0,90% | 304 156 NS | 30 de abril de 2026 | N-PORT |
| BSCQ · Invesco Exchange-Traded Self-Indexe… | 0,85% | 29 472 000 | 21 de agosto de 2026 | Diario |
| WBIG · Absolute Shares Trust | 0,82% | 2 495 NS | 30 de junio de 2026 | N-PORT |
| BIGY · Tidal Trust II | 0,82% | 2 364 NS | 30 de abril de 2026 | N-PORT |
| USMV · iShares Trust | 0,79% | 1 672 210 SH | 21 de agosto de 2026 | Diario |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,77% | 73 722 NS | 30 de abril de 2026 | N-PORT |
| CGDV · Capital Group Dividend Value ETF | 0,75% | 3 098 502 NS | 31 de mayo de 2026 | N-PORT |
| MGV · VANGUARD WORLD FUND | 0,75% | 1 094 793 SH | 19 de agosto de 2026 | Diario |
| DIVB · iShares Trust | 0,74% | 123 321 SH | 21 de agosto de 2026 | Diario |
| IWX · iShares Trust | 0,73% | 255 571 SH | 21 de agosto de 2026 | Diario |
| CAPE · DoubleLine ETF Trust | 0,72% | 18 972 NS | 30 de junio de 2026 | N-PORT |
| FEUS · FlexShares Trust | 0,72% | 8 721 NS | 30 de abril de 2026 | N-PORT |
| PFM · Invesco Exchange-Traded Fund Trust | 0,71% | 49 763 SH | 21 de agosto de 2026 | Diario |
| CGDG · Capital Group Dividend Growers ETF | 0,71% | 417 333 NS | 31 de mayo de 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,70% | 1 105 961 NS | 30 de abril de 2026 | N-PORT |
| FYEE · Fidelity Greenwood Street Trust | 0,69% | 12 637 NS | 30 de abril de 2026 | N-PORT |